Education news

ADHD Diagnoses Are Surging. A Diagnosis Is Not a Verdict.

ADHD diagnoses and prescriptions are climbing worldwide, and in England more adults than children now get stimulants. The number every parent hears is real. What it actually counts, and what it never measured, is the part worth keeping.

Laura Lurns Last updated August 24, 2026 · 9 min read

ADHD Diagnoses Are Surging. A Diagnosis Is Not a Verdict.

If a teacher has ever pulled you aside about your child’s focus, you know how fast the conversation bends toward one question: has he been evaluated? A new review from two Cambridge neuroscientists confirms, at scale, what that hallway conversation reflects. ADHD diagnoses and prescriptions are climbing worldwide, across every age group, and for the first time on record more adults than children are being prescribed stimulants in England. Those numbers are real, and they deserve to be taken seriously rather than waved away. But a diagnosis count answers one question, and it is not the one a parent most needs answered: whether a child’s attention is a fixed limit, or something that gets built.

TL;DR

A narrative review by Barbara Sahakian and Christelle Langley (University of Cambridge) in the Journal of Psychopharmacology drew together global research showing ADHD diagnoses and prescriptions rising across all age groups.
In UK primary care from 2000 to 2018 (McKechnie et al.), diagnoses among men aged 18 to 29 rose roughly 20-fold and prescriptions nearly 50-fold; absolute rates stayed highest in children, with recorded diagnoses in boys aged 10 to 16 going from 1.4% to 3.5%.
In England, stimulant prescriptions rose 32% in adults and 12% in children, and 2021 to 2022 was the first year on record that more adults than children were prescribed them.
A multinational study (Raman et al.) across roughly 154 million people in 13 countries plus one special administrative region found medication use rising across North America, Europe and Asia.
The primary UK authors caution that these are administrative (coded) diagnoses, not the community rate of symptoms, with multiple drivers including awareness, broadened criteria, overdiagnosis and misdiagnosis.

Context the coverage leaves out

What the coverage gets wrong

Most write-ups frame the surge as either unambiguous progress or an alarm bell, and in doing so drop the two caveats the primary researchers put front and center. First, these are administrative counts, coded diagnoses and filled prescriptions, which the UK study’s own authors say do not equal the community rate of children whose symptoms meet the criteria, and which they attribute to awareness, broadened definitions, genuine increases, overdiagnosis and misdiagnosis, all at once. A 20-fold rise in codes is not a 20-fold rise in the condition. Second, the data skews heavily toward adults, so “ADHD is exploding” partly means adults who were missed are finally being recognized, not simply that more children have it. Neither “everyone is overmedicated” nor “we are finally catching everyone” is what the evidence establishes. For a parent, the takeaway is narrower and steadier: a diagnosis marks where a child is today, and how it is framed decides whether it opens a door or closes one.

The global rise in ADHD diagnoses is making headlines, and it is easy to read into it more, or less, than the data actually says. Here are the questions parents are actually asking about what it means at home.

Common questions

Should I get my child evaluated for ADHD?

An evaluation opens real doors: self-understanding, accommodations at school, and medical options you would decide with a doctor. It also describes where your child is now, not where they are headed, so how it gets framed matters as much as whether it happens. A screener or an evaluation is a starting point, not a diagnosis. If your child might need formal accommodations such as an IEP or 504 plan, or you suspect a vision, hearing, or medical cause, pursue a professional evaluation too, since that is the only route to those supports.

Is ADHD being overdiagnosed?

The field itself has not settled this. Some researchers argue overdiagnosis is a real problem; others say there is no good evidence of it in the UK. What the primary data does show is that these are administrative counts of coded diagnoses, driven by a mix of genuine increases, wider awareness, broadened criteria, and yes, possible over- and misdiagnosis. The honest answer is that no single explanation accounts for the whole rise.

Is attention a fixed limit, or a skill a child builds?

Our position is that focus and attention are built through practice and the right support rather than being fixed limits, and we say that behaviorally, as something we see when children practice, not as a brain measurement or a cure for anything. This sits alongside, never instead of, whatever a family decides with their doctor, and it is not medical advice or a reason to change a prescribed plan. It simply means a child who struggles to focus is working on a skill, and skills grow.

My child was diagnosed. Does that mean they will always struggle?

A diagnosis describes where your child is today. It does not predict where they will be after a year of the right kind of practice. For some children a name for the struggle brings genuine relief; for others a label lowers expectations. The difference is the language wrapped around it, whether it is treated as a verdict or as a description of a starting point.

Share the idea

ADHD diagnoses and prescriptions are surging worldwide, and in England more adults than children now get stimulants. A diagnosis describes where a child is today, not a fixed limit.

Post on X Follow

What the review found

The story starts with a review in the Journal of Psychopharmacology by Barbara Sahakian and Christelle Langley, both University of Cambridge neuroscientists, who, in their words, “drew together the recently published research on ADHD diagnoses and prescriptions across the world.” The review is a narrative one, and the authors say so plainly: “This is a narrative review and consequently does not represent all articles published on this topic.” The striking figures it gathers come from earlier peer-reviewed studies, not from new data the authors collected. Their headline framing is that “ADHD, long thought of as a children’s disorder, is now being treated as what it truly is: a lifelong neurodevelopmental disorder affecting millions of people across the globe.”

The figures themselves are worth seeing directly. In UK primary care between 2000 and 2018, McKechnie and colleagues found that among men aged 18 to 29, diagnoses rose roughly 20-fold and prescriptions nearly 50-fold. Absolute rates stayed highest in children throughout the study: among boys aged 10 to 16, recorded diagnoses went from 1.4% to 3.5%, and prescriptions from 0.6% to 2.4%. In England, stimulant prescriptions rose 32% in adults in a single year and 12% in children, and 2021 to 2022 was the first year on record that more adults than children were prescribed these medications. A multinational study by Raman and colleagues, spanning roughly 154 million people across 13 countries plus one special administrative region, found medication use rising across North America, Europe and Asia.

The review does not paper over the debate underneath its own numbers. The authors flag competing explanations without resolving them, and note that the wait time for an ADHD diagnosis in England, by their account, now ranges from two to 15 years. So the picture is a rise that is real and a set of causes the field is still arguing about.

ADHD, long thought of as a children’s disorder, is now being treated as what it truly is: a lifelong neurodevelopmental disorder affecting millions of people across the globe.
Laura Lurns · Learning Success expert

The frame the science supports

Coverage of a trend like this tends to split into two tidy camps. One reads the surge as pure progress, the system finally catching adults and women who were missed for decades. The other reads it as an overmedication panic, ordinary childhood being relabeled. The honest answer is that the field itself has not settled which is which, and the more useful point sits underneath both: a diagnosis count is not a clean measure of how many children have a fixed condition. It is a record of how many were coded and prescribed for.

The primary UK study is unusually candid about exactly this. Its authors write that their data “captures administrative prevalence (the prevalence of coded ADHD diagnoses) and not the community prevalence of symptoms meeting the ADHD diagnostic criteria.” They list the drivers openly: increases “may have multiple drivers, which include a genuine increase… increasing awareness… changing attitudes… broadened diagnostic criteria… overdiagnosis; misdiagnosis…” A 20-fold rise in coded diagnoses, in other words, is not a 20-fold rise in the underlying thing. It is a rise in recognition, definition and prescribing, all moving at once.

Here is where we hold a line that the news does not draw. A diagnosis describes where a child is today. It does not predict where they will be after a year of the right kind of practice. And in our view, attention is not a fixed ceiling a child is stuck under. It is a skill that grows with practice and the right support, which is how we treat attention in our own work. That is our position, grounded in what we see when children practice focusing, not a finding from the ADHD research. None of the studies in this review measured whether attention gets built, because that is not the question they asked. We keep the two apart on purpose: the surge is a fact about diagnosis, and the buildability of attention is a lens we bring to what happens next.

Key takeaways

The surge is real: ADHD diagnoses and prescriptions are rising worldwide, across every age group.
A count is not a verdict: the primary study’s own authors call it administrative, not community, prevalence.
Attention is a skill: in our view it grows with practice and support, held apart from the diagnosis question.

What it means for your child

Most of the data behind these headlines is about adults, which is easy to file as somebody else’s story. It is not. The same model that is driving adult numbers, where a struggle to focus is read as a deficit to be diagnosed and medicated, is exactly the one a parent meets the moment a teacher raises a hand about a child. And in the UK figures, children were never out of the picture: their prescription rates rose too, and their absolute rates stayed the highest the whole time. So the decision lands on parents early.

Treat an evaluation the way you would treat any powerful tool: it helps or harms depending on how it is used. A diagnosis opens real doors, self-understanding, accommodations at school, and for some families medication decided with a doctor, and those medical decisions are yours to make, not anyone else’s to second-guess. The research on labels is honest that they cut both ways. For some children a name for the struggle brings relief and ends the self-blame; for others it arrives with no hope attached and quietly lowers everyone’s expectations. What tips it is not whether the label exists, it is the language wrapped around it, whether “ADHD” becomes a verdict a child files under “this is simply who I am” or a description of where they are right now. Alongside whatever medical path you choose, you are able to work the skill directly, in short, low-stakes bursts of practiced focus. A free focus guide is a place to start tonight.

One more thing worth knowing before you go looking for a single answer: attention rarely travels alone. It tends to sit beside working memory, confidence, and coordination, and each of those is worth building in its own right rather than counting on one to fix the others. A child whose focus wobbles is not a child with a fixed flaw. They are a child who has not yet built a skill that, like every other skill, is built.

Using data from real world sources, rather than clinical trials, we found that the prevalence of children and adults who have used ADHD medication is increasing in all countries.
Laura Lurns · Learning Success expert

You do not need a specialist’s vocabulary to make a good call for your child. You need to hold two things at once: the number in the headline is real, and it never described a fixed limit on who your child gets to become. Children are capable of building the exact thing they are being told they lack. The villain here is not a diagnosis, and it is certainly not medication a family chooses with their doctor. It is the older, stickier idea underneath the whole conversation, that a child who struggles to focus has a fixed deficit to be managed rather than a skill to be built, so a label gets read as a verdict and the growing quietly stops. That is the framing Learning Success was built to refuse. Our All-Access membership opens an assessment that asks about the processing systems your child’s learning runs on, attention among them, and a roadmap that names what to build first. It is a starting point for helping your child, not a diagnosis, and not a reason to change anything a doctor has advised.

See what All Access gives your child

Is your child struggling in school?

Get your free personalized learning roadmap

You describe what you see at home. We turn it into a plan you start this week.

Answer 5 short questionnaires about what you already notice, 30–45 minutes at your own kitchen table
Your child sits no test and gets no score: nothing to schedule, nothing for them to dread
You do the answering, the AI does the writing, and a person reviews it before it reaches you
Access all 40+ courses instantly: reading, math, focus, processing and more, with new ones added regularly

Why we use AI, plainly: it writes from a knowledge base our team maintains and audits. We work through it line by line and pull anything the evidence stops supporting. The roadmap you get on Tuesday reflects what we corrected on Monday, and a human still reads it before you do.

Your school district must evaluate your child free of charge if you ask in writing, whatever your income and whatever the outcome (US, 34 CFR 300.111 and 300.301(b)). That route takes time and answers a different question than you do. This one starts today, from what you already know.

Get my free assessment & 7-day trial Cancel anytime during your trial.

Your answers stay yours. We do not sell your personal information, and we do not hand identifiable assessment data to outside AI companies to train their models.

A screener is a starting point, not a diagnosis. If your child might need formal accommodations (an IEP or 504 plan), or you suspect a vision, hearing or medical cause, pursue a professional evaluation too. That is the only route to those supports.

References

McKechnie et al., BJPsych Open (2023) — ADHD diagnoses and prescriptions in UK primary care, 2000–2018: population-based cohort study
Raman et al., The Lancet Psychiatry, via Healio — ADHD medication use increases globally
Sahakian & Langley, Journal of Psychopharmacology (2026), DOI 10.1177/02698811261466620 — The increasing use of cognitive enhancing drugs by those with ADHD and neurotypical individuals
The Conversation — ADHD diagnoses and prescriptions have increased globally across all age groups, our review shows

Laura Lurns · Learning Success expert Writes about the learning brain for parents who want plain answers. Every article is grounded in current neuroscience and classroom practice.